Počet záznamů: 1  

Synthesis and neuroprotective activity of 3-aryl-3-azetidinyl acetic acid methyl ester derivatives

  1. 1.
    0578898 - ÚEB 2024 RIV US eng J - Článek v odborném periodiku
    Šachlevičiūtė, U. - Gonzalez, G. - Kvasnicová, M. - Štěpánková, Š. - Kleizienė, N. - Bieliauskas, A. - Zatloukal, M. - Strnad, Miroslav - Sløk, F. A. - Kvasnica, Miroslav - Šačkus, A. - Žukauskaitė, A.
    Synthesis and neuroprotective activity of 3-aryl-3-azetidinyl acetic acid methyl ester derivatives.
    Archiv der Pharmazie. Roč. 356, č. 12 (2023), č. článku 2300378. ISSN 0365-6233. E-ISSN 1521-4184
    Grant CEP: GA ČR(CZ) GA23-05389S
    Institucionální podpora: RVO:61389030
    Klíčová slova: acetylcholinesterase * Alzheimer disease * azetidine * neuroprotection * Parkinson disease
    Obor OECD: Biochemistry and molecular biology
    Impakt faktor: 5.1, rok: 2022
    Způsob publikování: Open access
    https://doi.org/10.1002/ardp.202300378

    A library of 3-aryl-3-azetidinyl acetic acid methyl ester derivatives was prepared from N-Boc-3-azetidinone employing the Horner-Wadsworth-Emmons reaction, rhodium(I)-catalyzed conjugate addition of arylboronic acids, and subsequent elaborations to obtain N-unprotected hydrochlorides, N-alkylated and N-acylated azetidine derivatives. The compounds were evaluated for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, revealing several derivatives to possess AChE inhibition comparable to that of the AChE inhibitor rivastigmine. The binding mode of the AChE inhibitor donepezil and selected active compounds 26 and 27 within the active site of AChE was studied using molecular docking. Furthermore, the neuroprotective activity of the prepared compounds was evaluated in models associated with Parkinson's disease (salsolinol-induced) and aspects of Alzheimer's disease (glutamate-induced oxidative damage). Compound 28 showed the highest neuroprotective effect in both salsolinol- and glutamate-induced neurodegeneration models, and its protective effect in the glutamate model was revealed to be driven by a reduction in oxidative stress and caspase-3/7 activity.
    Trvalý link: https://hdl.handle.net/11104/0347819

     
    Název souboruStaženoVelikostKomentářVerzePřístup
    2023_Sachleviciute_ARCHIV DER PHARMAZIE_e2300378..pdf13.6 MBJinápovolen
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.